YOLO vs. IBRN ETF Comparison
Comparison of AdvisorShares Pure Cannabis ETF (YOLO) to iShares Neuroscience and Healthcare ETF (IBRN)
YOLO
AdvisorShares Pure Cannabis ETF
YOLO Description
Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities. The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.
Grade (RS Rating)
Last Trade
$3.97
Average Daily Volume
77,741
10
IBRN
iShares Neuroscience and Healthcare ETF
IBRN Description
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$24.18
Average Daily Volume
312
47
Performance
| Period | YOLO | IBRN |
|---|---|---|
| 30 Days | 6.33% | 7.01% |
| 60 Days | 6.61% | -5.55% |
| 90 Days | 12.48% | -5.58% |
| 12 Months | 51.09% | -6.14% |
0 Overlapping Holdings
| Symbol | Grade | Weight in YOLO | Weight in IBRN | Overlap |
|---|
YOLO Underweight 47 Positions Relative to IBRN
| Symbol | Grade | Weight | |
|---|---|---|---|
| NBIX | C | -4.93% | |
| PTCT | C | -4.86% | |
| BIIB | C | -4.75% | |
| SRPT | C | -4.7% | |
| CERE | C | -4.7% | |
| AXNX | D | -4.56% | |
| ARGX | D | -4.36% | |
| ITCI | C | -4.24% | |
| XENE | D | -3.93% | |
| ALKS | F | -3.69% | |
| BHVN | F | -3.54% | |
| IART | F | -3.48% | |
| CPRX | C | -3.27% | |
| SUPN | F | -3.05% | |
| ACAD | F | -2.82% | |
| AVDL | C | -2.68% | |
| DYN | D | -2.28% | |
| EWTX | C | -2.18% | |
| PRTA | F | -2.17% | |
| SAVA | D | -1.69% | |
| SRRK | D | -1.55% | |
| LBPH | C | -1.33% | |
| WVE | D | -1.01% | |
| NMRA | F | -0.9% | |
| NVRO | F | -0.78% | |
| ALEC | F | -0.77% | |
| VYGR | D | -0.74% | |
| DNTH | D | -0.73% | |
| AVXL | F | -0.72% | |
| PEPG | B | -0.67% | |
| VNDA | B | -0.61% | |
| SLDB | D | -0.56% | |
| ANNX | D | -0.54% | |
| TRDA | C | -0.54% | |
| KYTX | F | -0.5% | |
| AXGN | F | -0.48% | |
| ANRO | D | -0.46% | |
| LRMR | D | -0.38% | |
| CAPR | D | -0.32% | |
| ABOS | F | -0.31% | |
| VTGN | F | -0.22% | |
| ABEO | F | -0.21% | |
| NPCE | F | -0.19% | |
| AMLX | F | -0.19% | |
| ATHA | F | -0.19% | |
| BWAY | C | -0.18% | |
| CVRX | F | -0.16% |
YOLO: Top Represented Industries & Keywords
IBRN: Top Represented Industries & Keywords
Compare ETFs
